Literature DB >> 21296726

["Malnutrition-inflammation complex syndrome" in chronic hemodialysis].

Pablo Young1, Fernando Lombi, Barbara C Finn, Mariano Forrester, Vicente Campolo-Girard, Vanesa Pomeranz, Romina Iriarte, Julio E Bruetman, Hernan Trimarchi.   

Abstract

Protein-energy wasting (PEW) and inflammation are usually common and concurrent conditions in maintenance dialysis patients and associated with poor prognosis. Low appetite and hypercatabolic states are common features. In dialysis patients, the former has been suggested to be secondary to inflammation; however, the evidence is not conclusive. Hence, the term malnutrition-inflammation complex syndrome (MICS) was coined to include this clinical entity, regardless the original causes. Possible causes of MICS include comorbid illnesses, oxidative stress, nutrient loss through dialysis, hyporexia, uremic toxins, decreased clearance of inflammatory cytokines, volume overload, increased blood phosphate and dialysis-related factors. MICS is believed to be the main cause of erythropoietin hypo-responsiveness, cardiovascular atherosclerotic disease, decreased quality of life, hospitalization and increased mortality in dialysis patients. Because MICS leads to a low body mass index, hypocholesterolemia, decrease in muscle mass, hypocreatininemia and hypohomocysteinemia, a "reverse epidemiology" phenomenon of cardiovascular risk factors can occur in dialysis patients. Therefore, obesity, hypercholesterolemia, and increased blood levels of creatinine and homocysteine, within certain limits, appear to be protective and paradoxically associated with a better outcome. There is no consensus about how to determine the degree of severity of MICS or how to manage it. Several diagnostic tools and treatment modalities are discussed in this paper. The correct management of MICS may diminish the cardiovascular disease, main cause of death in this population.

Entities:  

Mesh:

Year:  2011        PMID: 21296726

Source DB:  PubMed          Journal:  Medicina (B Aires)        ISSN: 0025-7680            Impact factor:   0.653


  7 in total

1.  The effects of megestrol acetate on nutrition, inflammation and quality of life in elderly haemodialysis patients.

Authors:  Zhigui Zheng; Jianguo Chen; Dongyuan He; Yuankai Xu; Lili Chen; Ting Zhang
Journal:  Int Urol Nephrol       Date:  2019-07-29       Impact factor: 2.370

2.  Effect of fish oil supplement in maintenance hemodialysis patients: a systematic review and meta-analysis of published randomized controlled trials.

Authors:  Lei He; Meng-si Li; Mei Lin; Tian-ya Zhao; Ping Gao
Journal:  Eur J Clin Pharmacol       Date:  2015-11-12       Impact factor: 2.953

3.  Malnutrition-inflammation score and quality of life in hemodialysis patients: is there any correlation?

Authors:  Zahra Sohrabi; Mohammad Hassan Eftekhari; Mohammad Hadi Eskandari; Abbas Rezaeianzadeh; Mohammad Mahdi Sagheb
Journal:  Nephrourol Mon       Date:  2015-05-23

4.  Association of estimated glomerular filtration rate with all-cause and cardiovascular mortality: the role of malnutrition-inflammation-cachexia syndrome.

Authors:  Shuo-Ming Ou; Yung-Tai Chen; Szu-Chun Hung; Chia-Jen Shih; Chi-Hung Lin; Chih-Kang Chiang; Der-Cherng Tarng
Journal:  J Cachexia Sarcopenia Muscle       Date:  2016-01-05       Impact factor: 12.910

5.  Inflammation, Appetite and Food Intake in Older Hospitalized Patients.

Authors:  Lars Sieske; Gregor Janssen; Nina Babel; Timm Henning Westhoff; Rainer Wirth; Maryam Pourhassan
Journal:  Nutrients       Date:  2019-08-22       Impact factor: 5.717

6.  The impact of acute changes of inflammation on appetite and food intake among older hospitalised patients.

Authors:  Maryam Pourhassan; Lars Sieske; Gregor Janssen; Nina Babel; Timm Henning Westhoff; Rainer Wirth
Journal:  Br J Nutr       Date:  2020-06-18       Impact factor: 3.718

7.  Diet-Related Inflammation is Associated with Malnutrition-Inflammation Markers in Maintenance Hemodialysis Patients: Results of a Cross-Sectional Study in China Using Dietary Inflammatory Index.

Authors:  Guixing Zeng; Jiarong Lin; Yaxing He; Chao Yuan; Yuchi Wu; Qizhan Lin
Journal:  Int J Gen Med       Date:  2022-04-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.